Weizmann Institute scientists develop a potential future treatment for myasthenia gravis

Weizmann Institute researchers have developed an effective treatment, administered through the nose, for a myasthenia gravis-like disease in rats, according to a report in the July 6 issue of the Proceedings of the National Academy of Sciences (PNAS).

The new approach used in the study may serve as a basis for treating myasthenia gravis in humans. "More studies will be necessary before applying our approach in clinical trials, but we have good reason to believe that an effective treatment for human patients can now be developed," said research team leader Prof. Sara Fuchs of the Institute's Immunology Department.

The team includes graduate students Dora Barchan and Sin-Hyeog Im, and Prof. Miriam Souroujon of The Open University in Tel Aviv.

Myasthenia gravis is an autoimmune disease in which the body's immune system mistakenly attacks the receptors in muscles that pick up acetylcholine, a chemical messenger that transmits signals from nerves to muscles. As these acetylcholine receptors are blocked by antibodies and progressively destroyed, the nerve-muscle communication is disrupted and the patient develops weakness in the muscles of the face, throat and limbs. In severe cases, paralysis of respiratory muscles can be life-threatening.

Currently, many patients with myasthenia gravis are given corticosteroid drugs that suppress the immune system, but these drugs may have undesirable side effects. An ideal treatment would suppress only the immune mechanism that goes awry in myasthenia gravis, without affecting the rest of the immune system.

For more than 20 years, Prof. Fuchs has worked with the animal model for myasthenia gravis, attempting to develop a treatment that would be specific for this disease.

In the study reported in PNAS, Fuchs's team genetically engineered a fragment of the human acetylcholine receptor -- the part of the receptor molecule that protrudes above the surface of muscle cells and reacts with various antibodies res

Contact: Jeffrey J. Sussman
American Committee for the Weizmann Institute of Science

Page: 1 2

Related medicine news :

1. Weizmann Institute receives $8 million grant from Flight Attendant Medical Research Institute
2. Weizmann Institute Prof. Moshe Oren named winner of NIH MERIT Award
3. Weizmann Women & Science Award to be presented to Dr. Carla J. Shatz; Millennial Lifetime Achievement Award to Dr. Mildred S. Dresselhaus
4. Gladstone Institutes rank high in the scientist survey of best places for postdocs
5. Institute of Medicine advisory: Jan. 12 Briefing on Complementary and Alternative Medicine
6. Research by scientists affiliated with the Earth Institute at Columbia University
7. New Jersey Institute of Technology pioneers new way to teach engineers
8. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
9. Six new Roybal Centers for Applied Gerontology established by National Institute on Aging
10. American College of Chest Physicians announces new Critical Care Institute
11. UGA professor receives $3 million grant from National Cancer Institute for breast cancer research

Post Your Comments:

(Date:7/22/2018)... ... 2018 , ... In an upcoming episode of “On Demand,” host Rob Lowe ... a type of medicine that considers the well-being the whole person when addressing an ... discipline that hones in on the curative relationship between the patient and medical profession, ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
Cached News: